Your browser doesn't support javascript.
loading
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia.
Steinmetz, T; Tschechne, B; Harlin, O; Klement, B; Franzem, M; Wamhoff, J; Tesch, H; Rohrberg, R; Marschner, N.
Affiliation
  • Steinmetz T; Outpatient Clinic for Oncology and Haematology, Cologne. Electronic address: steinmetz@oncokoeln.de.
  • Tschechne B; Klinikum Neustadt am Rübenberge, Neustadt am Rübenberge.
  • Harlin O; Vifor Pharma, Munich, Germany.
  • Klement B; Vifor Pharma, Glattbrugg, Switzerland.
  • Franzem M; iOMEDICO AG.
  • Wamhoff J; Oncology Practice, Osnabrueck.
  • Tesch H; Outpatient Clinic, Im Pruefling, Frankfurt.
  • Rohrberg R; Oncology Outpatient Clinic, Halle/Saale.
  • Marschner N; Practice for Oncology and Hematology, Freiburg, German.
Ann Oncol ; 24(2): 475-482, 2013 Feb.
Article in En | MEDLINE | ID: mdl-23071262
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Anemia, Iron-Deficiency / Maltose / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2013 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferric Compounds / Anemia, Iron-Deficiency / Maltose / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2013 Document type: Article